- Home
- BLE vs TOI Comparison
BLE vs TOI Comparison
Compare BLE & TOI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLE
- TOI
- Stock Information
- Founded
- BLE 2002
- TOI 2007
- Country
- BLE United States
- TOI United States
- Employees
- BLE N/A
- TOI N/A
- Industry
- BLE Finance/Investors Services
- TOI Medical/Nursing Services
- Sector
- BLE Finance
- TOI Health Care
- Exchange
- BLE Nasdaq
- TOI Nasdaq
- Market Cap
- BLE 475.4M
- TOI 393.4M
- IPO Year
- BLE N/A
- TOI N/A
- Fundamental
- Price
- BLE $10.32
- TOI $3.64
- Analyst Decision
- BLE
- TOI Strong Buy
- Analyst Count
- BLE 0
- TOI 1
- Target Price
- BLE N/A
- TOI $6.00
- AVG Volume (30 Days)
- BLE 108.3K
- TOI 1.7M
- Earning Date
- BLE 01-01-0001
- TOI 11-12-2025
- Dividend Yield
- BLE 4.46%
- TOI N/A
- EPS Growth
- BLE N/A
- TOI N/A
- EPS
- BLE 0.01
- TOI N/A
- Revenue
- BLE N/A
- TOI $424,376,000.00
- Revenue This Year
- BLE N/A
- TOI $21.71
- Revenue Next Year
- BLE N/A
- TOI $20.58
- P/E Ratio
- BLE $1,082.00
- TOI N/A
- Revenue Growth
- BLE N/A
- TOI 17.53
- 52 Week Low
- BLE $8.77
- TOI $0.13
- 52 Week High
- BLE $10.95
- TOI $4.50
- Technical
- Relative Strength Index (RSI)
- BLE 54.05
- TOI 59.01
- Support Level
- BLE $10.32
- TOI $3.35
- Resistance Level
- BLE $10.48
- TOI $3.58
- Average True Range (ATR)
- BLE 0.06
- TOI 0.22
- MACD
- BLE -0.02
- TOI 0.04
- Stochastic Oscillator
- BLE 5.83
- TOI 83.29
About BLE BlackRock Municipal Income Trust II
Blackrock Municipal Income Trust II is a perpetual closed-end municipal bond fund. Its objective is to provide high current income exempt from regular U.S. federal income tax consistent with the preservation of capital. The Fund seeks to achieve its investment objective by investing at least 80% of its assets in municipal obligations that pay interest that is exempt from U.S. federal income taxes (except that the interest may be subject to the U.S. federal alternative minimum tax).
About TOI The Oncology Institute Inc.
The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling. The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services. Majority of revenue is from patients services.